Cargando…
Bevacizumab-induced immunoglobulin A vasculitis with nephritis: A case report
RATIONALE: Bevacizumab—an inhibitor of vascular endothelial growth factor—is effective against various advanced cancers. However, it is associated with the development of hypertension and high-grade proteinuria during thrombotic microangiopathy of the kidney. In addition, there are several reports o...
Autores principales: | Endo, Yoko, Negishi, Kousuke, Hirayama, Kento, Suzuki, Hitoshi, Shimizu, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855607/ https://www.ncbi.nlm.nih.gov/pubmed/31702653 http://dx.doi.org/10.1097/MD.0000000000017870 |
Ejemplares similares
-
Acute tubulointerstitial nephritis with germinal centers in antineutrophil cytoplasmic antibody-associated vasculitis: A case report and literature review
por: Lin, Zi-Shan, et al.
Publicado: (2019) -
Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report
por: Tanabe, Katsuyuki, et al.
Publicado: (2021) -
Galactose-deficient IgA1 and nephritis-associated plasmin receptors as markers for IgA-dominant infection-related glomerulonephritis: A case report
por: Han, Wei, et al.
Publicado: (2021) -
Karyomegalic Interstitial Nephritis: A Case Report and Review of the Literature
por: Isnard, Pierre, et al.
Publicado: (2016) -
Cutaneous mucormycosis in a patient with lupus nephritis: A case report and review of literature
por: Cheng, Wenrong, et al.
Publicado: (2017)